Literature DB >> 10486358

Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat.

S S Poulsen1, J Thulesen, L Christensen, E Nexo, L Thim.   

Abstract

BACKGROUND: Trefoil factors (TFFs) are peptides produced by mucus-secreting cells in the gastrointestinal tract. A functional association between these peptides and mucus, leading to stabilisation of the viscoelastic gel overlying the epithelia, has been suggested. Both oral and parenteral administration of the peptides increase the resistance of the gastric mucosa. AIM: To study the effect in rats of oral and parenteral porcine trefoil factor 2 (pTFF2) on the healing of gastric and duodenal ulcerations and to clarify the distribution and metabolism of orally administered pTFF2 in the gastrointestinal tract.
METHODS: Gastric ulcers were induced in female Sprague-Dawley rats by indomethacin and duodenal ulcers by mercaptamine. The rats were treated for up to seven days with oral or subcutaneous pTFF2. Ulcer size after treatment was assessed by stereomicroscopy after whole mount staining with periodic acid-Schiff stain. (125)I-labelled pTFF2 was given orally to rats, and tissues were investigated by gamma counting of samples and by autoradiography of paraffin embedded sections.
RESULTS: pTFF2 accelerated gastric ulcer healing after both oral and subcutaneous administration. Duodenal ulcers were aggravated by both treatments. After oral administration of (125)I-pTFF2, intact peptide was recovered from the superficial part of the mucus layer in the stomach; it passed through the small intestine but was degraded in the caecum. Only a minor part of the labelled pTFF2 entered the colon and was excreted in the faeces. Most of the label was excreted in the urine.
CONCLUSIONS: Oral as well as parenteral pTFF2 accelerates the healing of gastric ulceration and aggravates duodenal ulcers. Oral pTFF2 binds to the mucus layer of the stomach and the small intestine but does not reach the colonic mucosa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486358      PMCID: PMC1727673          DOI: 10.1136/gut.45.4.516

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Pancreatic spasmolytic polypeptide protects the gastric mucosa but does not inhibit acid secretion or motility.

Authors:  C McKenzie; T Marchbank; R J Playford; W Otto; L Thim; M E Parsons
Journal:  Am J Physiol       Date:  1997-07

2.  Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family.

Authors:  S Suemori; K Lynch-Devaney; D K Podolsky
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 3.  Trefoil peptides: from structure to function.

Authors:  L Thim
Journal:  Cell Mol Life Sci       Date:  1997-12       Impact factor: 9.261

Review 4.  Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer.

Authors:  N A Wright; W Hoffmann; W R Otto; M C Rio; L Thim
Journal:  FEBS Lett       Date:  1997-05-19       Impact factor: 4.124

5.  Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting.

Authors:  X D Tan; W Hsueh; H Chang; K R Wei; F Gonzalez-Crussi
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

6.  Experimental model for production of perforating duodenal ulcers by cysteamine in the rat.

Authors:  H Selye; S Szabo
Journal:  Nature       Date:  1973-08-17       Impact factor: 49.962

7.  Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat.

Authors:  S S Poulsen; J Thulesen; E Nexø; L Thim
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

8.  Increased microvascular permeability and lesion formation during gastric hypermotility caused by indomethacin and 2-deoxy-D-glucose in the rat.

Authors:  K Takeuchi; M Okada; S Ebara; H Osano
Journal:  J Clin Gastroenterol       Date:  1990       Impact factor: 3.062

9.  Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues.

Authors:  N A Wright; R Poulsom; G W Stamp; P A Hall; R E Jeffery; J M Longcroft; M C Rio; C Tomasetto; P Chambon
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

10.  pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel.

Authors:  R Williams; G W Stamp; C Gilbert; M Pignatelli; E N Lalani
Journal:  J Cell Sci       Date:  1996-01       Impact factor: 5.285

View more
  20 in total

1.  Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice.

Authors:  J I Semple; J L Newton; B R Westley; F E May
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

3.  Proteomics in gastroparesis: unique and overlapping protein signatures in diabetic and idiopathic gastroparesis.

Authors:  Madhusudan Grover; Surendra Dasari; Cheryl E Bernard; Lakshmikanth L Chikkamenahalli; Katherine P Yates; Pankaj J Pasricha; Irene Sarosiek; Richard McCallum; Kenneth L Koch; Thomas L Abell; Braden Kuo; Robert J Shulman; Simon J Gibbons; Travis J McKenzie; Todd A Kellogg; Michael L Kendrick; James Tonascia; Frank A Hamilton; Henry P Parkman; Gianrico Farrugia
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-04       Impact factor: 4.052

4.  Systemically administered trefoil factors are secreted into the gastric lumen and increase the viscosity of gastric contents.

Authors:  S Kjellev; E Nexø; L Thim; S S Poulsen
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

5.  Trefoil factor 2 negatively regulates type 1 immunity against Toxoplasma gondii.

Authors:  Cortez McBerry; Charlotte E Egan; Reena Rani; Yanfen Yang; David Wu; Nicholas Boespflug; Louis Boon; Barbara Butcher; Julie Mirpuri; Simon P Hogan; Eric Y Denkers; Julio Aliberti; De'broski R Herbert
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

Review 6.  Trefoil Factor Peptides and Gastrointestinal Function.

Authors:  Eitaro Aihara; Kristen A Engevik; Marshall H Montrose
Journal:  Annu Rev Physiol       Date:  2016-12-15       Impact factor: 19.318

7.  Proteolytic effects of gingipains on trefoil factor family peptides.

Authors:  Ponlatham Chaiyarit; Janthima Jaresitthikunchai; Narumon Phaonakrop; Sittiruk Roytrakul; Barbara Potempa; Jan Potempa
Journal:  Clin Oral Investig       Date:  2017-07-19       Impact factor: 3.573

8.  Altered expression of a putative progenitor cell marker DCAMKL1 in the rat gastric mucosa in regeneration, metaplasia and dysplasia.

Authors:  Miho Kikuchi; Hiroshi Nagata; Norihito Watanabe; Hiromitsu Watanabe; Masayuki Tatemichi; Toshifumi Hibi
Journal:  BMC Gastroenterol       Date:  2010-06-18       Impact factor: 3.067

9.  Role of TFF in healing of stress-induced gastric lesions.

Authors:  Shi-Nan Nie; Xiao-Ming Qian; Xue-Hao Wu; Shi-Yu Yang; Wen-Jie Tang; Bao-Hua Xu; Fang Huang; Xin Lin; Dong-Yan Sun; Hai-Chen Sun; Zhao-Shen Li
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  Preventive effect of hydrotalcite on gastric mucosal injury in rats induced by taurocholate.

Authors:  Bao-Ping Yu; Jun Sun; Mu-Qi Li; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.